Norfloxacina Eg

Norfloxacin, the active ingredient in Norfloxacina Eg, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It is employed to treat bacterial infections such as urinary tract infections, prostatitis and gonorrhea in adult patients. GNH USA supplies Norfloxacina Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norfloxacin is a broad‑spectrum antibacterial that targets Gram‑negative and some Gram‑positive organisms in several infection sites. - Urinary tract infections: eradicates the causative bacteria, relieving symptoms and preventing recurrence. - Prostatitis: penetrates prostatic tissue to eliminate infection and reduce inflammation. - Gonorrhea: combats Neisseria gonorrhoeae, aiding in the resolution of genital infection.

Norfloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional sense of light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT prolongation: cardiac rhythm disturbance that may lead to arrhythmia. - Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention.

Before prescribing Norfloxacina Eg, clinicians should consider several safety aspects. - Renal impairment: adjust therapy as clearance may be reduced. - History of tendon disorders: avoid use in patients with prior tendon injury. - Concomitant QT‑prolonging drugs: monitor cardiac rhythm closely. - Pregnancy and lactation: use only if potential benefit outweighs risk. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Norfloxacin can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce absorption of norfloxacin. - Warfarin: may increase anticoagulant effect, raising bleeding risk. - Cyclosporine: can elevate serum levels, leading to nephrotoxicity.

Moderate Interactions (Monitor Closely): - Theophylline: may increase plasma concentrations, causing toxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): concurrent use may raise risk of central nervous system stimulation.